(ENTA)—Is MRK's Cubist acqusition grounds to update the $25M of value to which you ascribed ENTA's biocyclolide antibiotic in your analysis at #msg-94993406? Maybe. What value would you think is appropriate? Other opinions welcome. IMO lot more if it can treat gram-negative